相关实验视频

Updated: Jun 17, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

CYB561是乳腺癌的潜在治疗点,与免疫细胞透有关

Jian Zhuo¹, Yanchun Zhao², Ruiying Hao³

¹Department of Breast Surgery, Yangzhou Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yangzhou, 225007, Jiangsu, China.

European journal of medical research

|August 12, 2024

概括

乳腺癌 (BC) 中高细胞染色体b561 (CYB561) 水平表明预后不佳. CYB561促进了BC的进展,并与免疫细胞的变化有关,这表明它是潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

乳腺癌 (BC) 是女性的重大健康问题.
以前的研究表明,细胞染色体b561 (CYB561) 与BC预后不佳之间存在联系,但机制尚不清楚.

研究的目的:

研究CYB561在乳腺癌进展中的作用和机制.
探索CYB561的预后价值及其与瘤免疫微环境的关联.

主要方法:

使用公共数据库 (TCGA,GEO,KM绘图器) 在BC分析了CYB561mRNA表达.
在158个BC患者样本中评估了CYB561蛋白质预后值.
利用体外和体内实验来研究CYB561对BC进展的影响.
进行基因表达,通路和丰富分析,以探索CYB561的功能.
使用CIBERSORT和单细胞分析评估了CYB561与BC免疫微环境的相关性.

主要成果:

升高的CYB561表达与不良的BC预后相关.
在体内,CYB561 knockdown 抑制了BC细胞的增殖,迁移,入侵和瘤形成.
CYB561调节了热氨酸1的表达,并且与BC免疫微环境中的M2巨分化有关.

结论:

升高的CYB561表达是乳腺癌的不良预后标志物.
CYB561与BC微环境中的M2巨分化有关.
CYB561代表了乳腺癌治疗的潜在治疗标.

关键词:

生物信息学是一种生物信息学.乳腺癌 (BC) 是一种癌症.细胞染色体b561 (CYB561) 是一种细胞染色体.免疫系统的透.预测预后预测预测一个单细胞序列的序列.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...